Perrigo (PRGO) Buildings (2015 - 2016)
Perrigo (PRGO) posted quarterly Buildings of $520.2 million for Q4 2016, up 2.36% year-over-year from $508.2 million in Q1 2016, and up 2.36% quarter-over-quarter from $508.2 million in Q4 2015.
Perrigo (PRGO) Buildings (2015 - 2016) Analysis & Trends
Perrigo (PRGO) has reported Buildings for 2 consecutive years, with $520.2 million the latest figure, recorded in Q4 2016.
- In Q4 2016, Buildings rose 2.36% year-over-year to $520.2 million; the TTM figure through Dec 2016 stood at $520.2 million (up 2.36% YoY), while the FY2016 annual figure was $520.2 million, up 2.36% from the prior year.
- Buildings climbed to $520.2 million in Q4 2016 per PRGO's latest filing, from $508.2 million in the prior quarter.
- Across five years, Buildings topped out at $528.3 million in Q2 2015 and bottomed at $508.2 million in Q4 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Perrigo | 1.93 Bn | 1.53 Bn | 313.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 520.20 Mn |
| Dec 31, 2015 | 508.20 Mn |
| Jun 27, 2015 | 528.30 Mn |